These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 19671562

  • 1. Use of recombinant activated factor VII for intractable bleeding in patients without hemophilia: A developing country tertiary care center's experience.
    Musallam KM, Saad GS, Majdalani MN, Muwakkit SA, Bou-Khalil PK, Aoun EG, Sawaya RA, Khalil I, Taher AT.
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):658-62. PubMed ID: 19671562
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [Abstract] [Full Text] [Related]

  • 4. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM, Easley RB, Tobias JD.
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [Abstract] [Full Text] [Related]

  • 5. A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes.
    MacLaren R, Weber LA, Brake H, Gardner MA, Tanzi M.
    Transfusion; 2005 Sep; 45(9):1434-42. PubMed ID: 16131375
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
    Bishop CV, Renwick WE, Hogan C, Haeusler M, Tuckfield A, Tatoulis J.
    Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
    [Abstract] [Full Text] [Related]

  • 9. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
    Key NS, Aledort LM, Beardsley D, Cooper HA, Davignon G, Ewenstein BM, Gilchrist GS, Gill JC, Glader B, Hoots WK, Kisker CT, Lusher JM, Rosenfield CG, Shapiro AD, Smith H, Taft E.
    Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prolonged prothrombin time after recombinant activated factor VII therapy in critically bleeding trauma patients is associated with adverse outcomes.
    McMullin NR, Wade CE, Holcomb JB, Nielsen TG, Rossaint R, Riou B, Rizoli SB, Kluger Y, Choong PI, Warren B, Tortella BJ, Boffard KD, NovoSeven Trauma Study Group.
    J Trauma; 2010 Jul; 69(1):60-9. PubMed ID: 20622579
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of recombinant activated Factor VII in patients with massive uncontrolled bleeding: a retrospective observational analysis.
    Berkhof FF, Eikenboom JC.
    Transfusion; 2009 Mar; 49(3):570-7. PubMed ID: 19040498
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage.
    Franchini M, Lippi G, Franchi M.
    BJOG; 2007 Jan; 114(1):8-15. PubMed ID: 17233855
    [Abstract] [Full Text] [Related]

  • 17. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors.
    Giangrande PL, Wilde JT, Madan B, Ludlam CA, Tuddenham EG, Goddard NJ, Dolan G, Ingerslev J.
    Haemophilia; 2009 Mar; 15(2):501-8. PubMed ID: 19187194
    [Abstract] [Full Text] [Related]

  • 18. Intraoperative use of recombinant activated factor VII (rFVIIa).
    De Gasperi A.
    Minerva Anestesiol; 2006 Jun; 72(6):489-94. PubMed ID: 16682921
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S, Sørensen B, Poulsen LH, Ingerslev J.
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.